In the world of clinical R&D technology solutions, we commonly are asked to be able to provide our groundbreaking information TrialCentralNet® portal in multiple languages.
What should we do when one site out of a large multinational campaign says, “Advertising isn’t working for me” when it’s clearly having a very positive effect on overall screening rates for the study?
"Think about it. One absolutely cannot tell, by watching, the difference between a .300 hitter and a .275 hitter. The difference is one hit every two weeks. It might be that a reporter, seeing every game that a team plays, could sense that difference over the course of the year if no records were kept, but I doubt it . . . . The difference between a good hitter and an average hitter is simply not visible – it is a matter of record. But the hitter is the center of attention . . . . If gross miscalculations of a person’s value could occur on a baseball field, before a live audience of 30,000, and a television audience of millions more, what did that say about the measurement of performance in other lines of work?" M. Lewis., 2004. "MoneyBall: The Art of Winning an Unfair Game." Chapter Four: Field of Ignorance, p 72.
BBK Worldwide Introduces eBinderSM 2 at the 47th Annual Meeting of the Drug Information Association (DIA) in Chicago.
Patient Recruitment Software Leader Introduces Smartphone Application and 11 New Languages to TrialCentralNetSM